HIV-associated Hodgkin's lymphoma: Prognosis and therapy in the era of cART

Advances in Hematology

Volumn 2012, Issue , 2012, Pages

  Jacobson, Caron A ^a   Abramson, Jeremy S ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; NAVELBINE; PREDNISONE; VINBLASTINE;

ANTIVIRAL THERAPY; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER STAGING; DISEASE ASSOCIATION; FOLLOW UP; HODGKIN DISEASE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RISK ASSESSMENT; TOXICITY TESTING; TREATMENT OUTCOME;

EID: 84856373674     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2012/507257     Document Type: Article

References (63)

1. Detels R., Muoz A., McFarlane G., Kingsley L. A., Margolick J. B., Giorgi J., Schrager L. K., Phair J. P., Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration Journal of the American Medical Association 1998 280 17 1497 1503 (Pubitemid 28507402)
2. Palella F. J. Jr., Delaney K. M., Moorman A. C., Loveless M. O., Fuhrer J., Satten G. A., Aschman D. J., Holmberg S. D., Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection The New England Journal of Medicine 1998 338 13 853 860 (Pubitemid 28135961)
3. Shiels M. S., Pfeiffer R. M., Gail M. H., Hall H. I., Li J., Chaturvedi A. K., Bhatia K., Uldrick T. S., Yarchoan R., Goedert J. J., Engels E. A., Cancer burden in the HIV-infected population in the United States Journal of the National Cancer Institute 2011 103 9 753 762
4. Powles T., Robinson D., Stebbing J., Shamash J., Nelson M., Gazzard B., Mandelia S., Mller H., Bower M., Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection Journal of Clinical Oncology 2009 27 6 884 890
5. Bedimo R. J., McGinnis K. A., Dunlap M., Rodriguez-Barradas M. C., Justice A. C., Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART Era: impact of immunosuppression Journal of Acquired Immune Deficiency Syndromes 2009 52 2 203 208
6. Marin B., Thiébaut R., Bucher H. C., Rondeau V., Costagliola D., Dorrucci M., Hamouda O., Prins M., Walker S., Porter K., Sabin C., Chne G., Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy AIDS 2009 23 13 1743 1753
7. Franceschi S., Lise M., Clifford G. M., Rickenbach M., Levi F., Maspoli M., Bouchardy C., Dehler S., Jundt G., Ess S., Bordoni A., Konzelmann I., Frick H., Dal Maso L., Elzi L., Furrer H., Calmy A., Cavassini M., Ledergerber B., Keiser O., Changing patterns of cancer incidence in the early-and late-HAART periods: the Swiss HIV Cohort Study British Journal of Cancer 2010 103 3 416 422
8. Simard E. P., Pfeiffer R. M., Engels E. A., Spectrum of cancer risk late after AIDS onset in the United States Archives of Internal Medicine 2010 170 15 1337 1345
9. Siegel R., Ward E., Brawley O., Jemal A., Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer Journal for Clinicians 2011 61 4 212 236
10. Ries L. A., Kosary C. L., Hankey B. F., SEER Cancer Statistics Review: 19731994 1997 Bethesda, Md, USA National Cancer Institute NIH publ no. 97-2789
11. Chimienti E., Spina M., Gastaldi R., Clinical characteristics and outcome of 290 patients (pts) with Hodgkins disease and HIV infection (HD-HIV) in pre and HAART (highly active anti-retroviral therapy) era Annals of Oncology 2008 19. abstract no. 168
12. Hessol N. A., Katz M. H., Liu J. Y., Buchbinder S. P., Rubino C. J., Holmberg S. D., Increased incidence of Hodgkin disease in homosexual men with HIV infection Annals of Internal Medicine 1992 117 4 309 311
13. Serraino D., Carbone A., Franceschi S., Tirelli U., Increased frequency of lymphocyte depletion and mixed cellularity subtypes of Hodgkin's disease in HIV-infected patients European Journal of Cancer A 1993 29 14 1948 1950 (Pubitemid 23324350)
14. Levine A. M., Hodgkin lymphoma: to the HAART of the matter Blood 2006 108 12 3630 3631
15. Biggar R. J., Jaffe E. S., Goedert J. J., Chaturvedi A., Pfeiffer R., Engels E. A., Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS Blood 2006 108 12 3786 3791 (Pubitemid 44864560)
16. Grogg K. L., Miller R. F., Dogan A., HIV infection and lymphoma Journal of Clinical Pathology 2007 60 12 1365 1372 (Pubitemid 350247252)
17. Tirelli U., Errante D., Dolcetti R., Gloghini A., Serraino D., Vaccher E., Franceschi S., Boiocchi M., Carbone A., Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors Journal of Clinical Oncology 1995 13 7 1758 1767
18. Carbone A., Gloghini A., Larocca L. M., Antinori A., Falini B., Tirelli U., Dalla-Favera R., Gaidano G., Human immunodeficiency virus-associated Hodgkin's disease derives from post-germinal center B cells Blood 1999 93 7 2319 2326 (Pubitemid 29153635)
19. Rezk S. A., Weiss L. M., Epstein-Barr virus-associated lymphoproliferative disorders Human Pathology 2007 38 9 1293 1304 (Pubitemid 47247493)
20. Said J. W., Immunodeficiency-related hodgkin lymphoma and its mimics Advances in Anatomic Pathology 2007 14 3 189 194 (Pubitemid 46659189)
21. Carbone A., Gloghini A., Dotti G., EBV-associated lymphoproliferative disorders: classification and treatment Oncologist 2008 13 5 577 585 (Pubitemid 351872874)
22. Guiguet M., Boué F., Cadranel J., Lang J. M., Rosenthal E., Costagliola D., Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study The Lancet Oncology 2009 10 12 1152 1159
23. Andrieu J. M., Roithmann S., Tourani J. M., Levy R., Desablens B., Le Maignan C., Gastaut J. A., Brice P., Raphael M., Taillan B., Hodgkin's disease during HIV1 infection: the French registry experience Annals of Oncology 1993 4 8 635 641 (Pubitemid 23291808)
24. Rubio R., Hodgkin's disease associated with human immunodeficiency virus infection: a clinical study of 46 cases Cancer 1994 73 9 2400 2407 (Pubitemid 24129126)
25. Hasenclever D., Diehl V., A prognostic score for advanced Hodgkin's disease The New England Journal of Medicine 1998 339 21 1506 1514 (Pubitemid 28543499)
26. Berenguer J., Miralles P., Ribera J. M., Rubio R., Valencia E., Mahillo B., Pintado V., Palacios R., Montes M. L., Téllez M. J., La Cruz J., Torre-Cisneros J., Rodrguez-Arrondo F., Seplveda M. A., Gutiérrez F., Peralta G., Boix V., Characteristics and outcome of AIDS-related hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 2008 47 4 422 428 (Pubitemid 351366959)
27. Gérard L., Galicier L., Boulanger E., Quint L., Lebrette M. G., Mortier E., Meignin V., Oksenhendler E., Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy AIDS 2003 17 1 81 87 (Pubitemid 36106301)
28. Hoffmann C., Chow K. U., Wolf E., Faetkenheuer G., Stellbrink H. J., Van Lunzen J., Jaeger H., Stoehr A., Plettenberg A., Wasmuth J. C., Rockstroh J., Mosthaf F., Horst H. A., Brodt H. R., Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease British Journal of Haematology 2004 125 4 455 462 (Pubitemid 38916190)
29. Hutchings M., Loft A., Hansen M., Pedersen L. M., Berthelsen A. K., Keiding S., D'Amore F., Boesen A. M., Roemer L., Specht L., Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma Haematologica 2006 91 4 482 489
30. Pakos E. E., Fotopoulos A. D., Ioannidis J. P. A., 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis Journal of Nuclear Medicine 2005 46 6 958 963 (Pubitemid 43733510)
31. Levine A. M., Li P., Cheung T., Tulpule A., Von Roenn J., Nathwani B. N., Ratner L., Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS Clinical Trials Group Study (ACTG 149) Journal of Acquired Immune Deficiency Syndromes 2000 24 5 444 450
32. Errante D., Tirelli U., Gastaldi R., Milo D., Nosari A. M., Rossi G., Fiorentini G., Carbone A., Vaccher E., Monfardini S., Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection: a prospective study of 17 patients Cancer 1994 73 2 437 444 (Pubitemid 24030626)
33. Errante D., Gabarre J., Ridolfo A. L., Rossi G., Nosari A. M., Gisselbrecht C., Kerneis Y., Mazzetti F., Vaccher E., Talamini R., Carbone A., Tirelli U., Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF Annals of Oncology 1999 10 2 189 195 (Pubitemid 29113179)
34. Xicoy B., Ribera J. M., Miralles P., Berenguer J., Rubio R., Mahillo B., Valencia M. E., Abella E., Lpez-Guillermo A., Sureda A., Morgades M., Navarro J. T., Esteban H., Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma Haematologica 2007 92 2 191 198
35. Spina M., Gabarre J., Rossi G., Fasan M., Schiantarelli C., Nigra E., Mena M., Antinori A., Ammassari A., Talamini R., Vaccher E., Di Gennaro G., Tirelli U., Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection Blood 2002 100 6 1984 1988 (Pubitemid 35001227)
36. Hartmann P., Rehwald U., Salzberger B., Franzen C., Sieber M., Whrmann A., Diehl V., BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection Annals of Oncology 2003 14 10 1562 1569 (Pubitemid 37304614)
37. Spina M., Rossi G., Antinori A., VEBEP regimen and highly active antiretroviral therapy (HAART) in patients (pts) with HD and HIV infection (HD-HIV): final results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study Annals of Oncology 2010 21, supplement 8. abstract no. 1148
38. Gabarre J., Marcelin A. G., Azar N., Choquet S., Lévy V., Lévy Y., Tubiana R., Charlotte F., Norol F., Calvez V., Spina M., Vernant J. P., Autran B., Leblond V., High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease Haematologica 2004 89 9 1100 1108 (Pubitemid 39295481)
39. Krishnan A., Molina A., Zaia J., Smith D., Vasquez D., Kogut N., Falk P. M., Rosenthal J., Alvarnas J., Forman S. J., Durable remissions with autologous stem cell transplantation for high-risk HTV-associated lymphomas Blood 2005 105 2 874 878 (Pubitemid 40070778)
40. Serrano D., Carrin R., Balsalobre P., Miralles P., Berenguer J., Buo I., Gmez-Pineda A., Ribera J. M., Conde E., Dez-Martn J. L., HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation Experimental Hematology 2005 33 4 487 494 (Pubitemid 40387632)
41. Spitzer T. R., Ambinder R. F., Lee J. Y., Kaplan L. D., Wachsman W., Straus D. J., Aboulafia D. M., Scadden D. T., Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS malignancy consortium study 020 Biology of Blood and Marrow Transplantation 2008 14 1 59 66 (Pubitemid 350286736)
42. Balsalobre P., Dez-Martn J. L., Re A., Michieli M., Ribera J. M., Canals C., Rosselet A., Conde E., Varela R., Cwynarski K., Gabriel I., Genet P., Guillerm G., Allione B., Ferrant A., Biron P., Espigado I., Serrano D., Sureda A., Autologous stem-cell transplantation in patients with HIV-related lymphoma Journal of Clinical Oncology 2009 27 13 2192 2198
43. Re A., Michieli M., Casari S., Allione B., Cattaneo C., Rupolo M., Spina M., Manuele R., Vaccher E., Mazzucato M., Abbruzzese L., Ferremi P., Carosi G., Tirelli U., Rossi G., High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors Blood 2009 114 7 1306 1313
44. Dez-Martn J. L., Balsalobre P., Re A., Michieli M., Ribera J. M., Canals C., Conde E., Rosselet A., Gabriel I., Varela R., Allione B., Cwynarski K., Genet P., Espigado I., Biron P., Schmitz N., Hunter A. E., Ferrant A., Guillerm G., Hentrich M., Jurado M., Fernndez P., Serrano D., Rossi G., Sureda A., Comparable survival between HIV + and HIV - non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation Blood 2009 113 23 6011 6014
45. Straus D. J., Portlock C. S., Qin J., Myers J., Zelenetz A. D., Moskowitz C., Noy A., Goy A., Yahalom J., Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease Blood 2004 104 12 3483 3489 (Pubitemid 39564416)
46. Meyer R. M., Gospodarowicz M. K., Connors J. M., Pearcey R. G., Bezjak A., Wells W. A., Burns B. F., Winter J. N., Horning S. J., Dar A. R., Djurfeldt M. S., Ding K., Shepherd L. E., Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma Journal of Clinical Oncology 2005 23 21 4634 4642
47. Canellos G. P., Abramson J. S., Fisher D. C., LaCasce A. S., Treatment of favorable, limited-stage Hodgkin's lymphoma with chemotherapy without consolidation by radiation therapy Journal of Clinical Oncology 2010 28 9 1611 1615
48. Linch D. C., Winfield D., Goldstone A. H., Moir D., Hancock B., McMillan A., Chopra R., Milligan D., Vaughan Hudson G., Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial The Lancet 1993 341 8852 1051 1054 (Pubitemid 23114397)
49. Schmitz N., Pfistner B., Sextro M., Sieber M., Carella A. M., Haenel M., Boissevain F., Zschaber R., Mller P., Kirchner H., Lohri A., Decker S., Koch B., Hasenclever D., Goldstone A. H., Diehl V., Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial The Lancet 2002 359 9323 2065 2071 (Pubitemid 34680969)
50. Re A., Cattaneo C., Michieli M., Casari S., Spina M., Rupolo M., Allione B., Nosari A., Schiantarelli C., Vigan M., Izzi I., Ferremi P., Lanfranchi A., Mazzuccato M., Carosi G., Tirelli U., Rossi G., High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy Journal of Clinical Oncology 2003 21 23 4423 4427 (Pubitemid 46621820)
51. Sandherr M., Einsele H., Hebart H., Kahl C., Kern W., Kiehl M., Massenkeil G., Penack O., Schiel X., Schuettrumpf S., Ullmann A. J., Cornely O. A., Antiviral prophylaxis in patients with haematological malignancies and solid tumours: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO) Annals of Oncology 2006 17 7 1051 1059 (Pubitemid 43985238)
52. Gupta V., Tomblyn M., Pederson T., Allogeneic hematopoietic stem cell transplantation in HIV-positive patients with malignant and non-malignant disorders: a report from the Center for International Blood and Marrow Transplant Research (CIBMTR) Blood 2006 108
53. Chen R. W., Gopal A. K., Smith S. M., Results from a pivotal phase II study of brentuximab vedotin (SGN-35) in patients with relapsed or refractory Hodgkin lymphoma (HL) Journal of Clinical Oncology 2011 29. abstract no. 8031
54. Jerusalem G., Beguin Y., Fassotte M. F., Najjar F., Paulus P., Rigo P., Fillet G., Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging Blood 1999 94 2 429 433 (Pubitemid 29323856)
55. Hutchings M., Loft A., Hansen M., Pedersen L. M., Buhl T., Jurlander J., Buus S., Keiding S., D'Amore F., Boesen A. M., Berthelsen A. K., Specht L., FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma Blood 2006 107 1 52 59 (Pubitemid 43053523)
56. Zinzani P. L., Tani M., Fanti S., Alinari L., Musuraca G., Marchi E., Stefoni V., Castellucci P., Fina M., Farshad M., Pileri S., Baccarani M., Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients Annals of Oncology 2006 17 8 1296 1300 (Pubitemid 44288221)
57. Gallamini A., Hutchings M., Rigacci L., Specht L., Merli F., Hansen M., Patti C., Loft A., Di Raimondo F., D'Amore F., Biggi A., Vitolo U., Stelitano C., Sancetta R., Trentin L., Luminari S., Iannitto E., Viviani S., Pierri I., Levis A., Early interim 2-[ 18 F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study Journal of Clinical Oncology 2007 25 24 3746 3752 (Pubitemid 47372616)
58. Barnes J. A., LaCasce A. S., Zukotynski K., Israel D., Feng Y., Neuberg D., Toomey C. E., Hochberg E. P., Canellos G. P., Abramson J. S., End-of-treatment but not interim PET scan predicts outcome in nonbulky limited-stage Hodgkin's lymphoma Annals of Oncology 2011 22 4 910 915
59. Dunleavy K., Little R. F., Pittaluga S., Grant N., Wayne A. S., Carrasquillo J. A., Steinberg S. M., Yarchoan R., Jaffe E. S., Wilson W. H., The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma Blood 2010 115 15 3017 3024
60. Antoniou T., Tseng A. L., Interactions between antiretrovirals and antineoplastic drug therapy Clinical Pharmacokinetics 2005 44 2 111 145 (Pubitemid 40188937)
61. Bower M., McCall-Peat N., Ryan N., Davies L., Young A. M., Gupta S., Nelson M., Gazzard B., Stebbing J., Protease inhibitors potentiate chemotherapy-induced neutropenia Blood 2004 104 9 2943 2946 (Pubitemid 39434985)
62. Tan B., Ratner L., The use of new antiretroviral therapy in combination with chemotherapy Current Opinion in Oncology 1997 9 5 455 464 (Pubitemid 27435043)
63. Michieli M., Mazzucato M., Tirelli U., De Paoli P., Stem cell transplantation for lymphoma patients with HIV infection Cell Transplantation 2011 20 351 370